Cure My Disease

Don't miss your cure!

 Log in / Sign up

Magnetic chair may help men regain bladder control faster after prostate surgery

NCT ID NCT07698028

Disease control Sponsor: Tanta University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study investigates whether adding a non-invasive magnetic stimulation treatment to standard pelvic floor exercises helps men recover bladder control more quickly after prostate surgery for an enlarged prostate. Participants who experience urine leakage after surgery will be randomly assigned to do pelvic floor exercises alone or exercises plus magnetic stimulation sessions using a specialized chair. Researchers will track how long it takes for bladder control to return, how much leakage occurs, and the impact on quality of life over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Extracorporeal Magnetic Stimulation (ExMI) via a specialized chair
What this could lead to
If it works, this could offer a non-invasive, drug-free way to speed up bladder control recovery after prostate surgery, improving quality of life.
What could go wrong
This is a relatively small, early-stage trial. The added benefit of magnetic stimulation over exercises alone may be modest, and results may not apply to all types of prostate surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male patients aged ≥50 years * Diagnosed with symptomatic benign prostatic hyperplasia (BPH) requiring surgical intervention * Scheduled for Holmium Laser Enucleation of the Prostate (HoLEP) or Bipolar Enucleation of the Prostate (BipoLEP) * Development of postoperative stress-predominant urinary incontinence after catheter removal * Presence of postoperative urinary leakage requiring at least one safety pad/day * Ability to understand and perform pelvic floor muscle training instructions * Ability and willingness to attend extracorporeal magnetic stimulation sessions and follow-up visits Exclusion Criteria: * Preoperative urinary incontinence or neurogenic bladder dysfunction * Previous prostate surgery or prior anti-incontinence surgery * Urethral stricture disease or bladder neck contracture * Active urinary tract infection at the time of enrollment * Severe cognitive impairment preventing compliance with PFMT instructions * Neurological disorders affecting lower urinary tract function, including Parkinson disease, multiple sclerosis, spinal cord injury, or cerebrovascular stroke with residual deficits * Implanted electronic or metallic devices contraindicating magnetic stimulation, including cardiac pacemaker, implantable cardioverter-defibrillator, neurostimulators, or cochlear implants * Uncontrolled diabetes mellitus with severe neuropathy * Receiving concurrent therapies for urinary incontinence during the study period * Persistent postoperative complications requiring reintervention (e.g., severe hematuria, clot retention) * Inability or refusal to complete follow-up evaluations

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Benign prostatic hyperplasia Post-prostatectomy urinary incontinence

Contacts and locations

Locations

  • Tanta University Hospital

    Tanta, 31111, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.